Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilization of the Natural History of Medullary Thyroid Carcinoma to Inform Advanced Disease Management

NCT04216732 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04216732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04216732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilization of the Natural History of Medullary Thyroid Carcinoma to Inform Advanced Disease Management
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
January 10, 2020
Completion date
September 1, 2028
Enrollment
2,030 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced thyroid gland medullary carcinoma, stage iii thyroid gland medullary carcinoma ajcc v8, stage iv thyroid gland medullary carcinoma ajcc v8, stage iva thyroid gland medullary carcinoma ajcc v8, stage ivb thyroid gland medullary carcinoma ajcc v8, stage ivc thyroid gland medullary carcinoma ajcc v8